Allianca Saude e Participacoes SA (BSP:AALR3)

Q2 2025 Allianca Saude e Participacoes SA Earnings Call Transcript

Aug 15, 2025 / 04:30 PM GMT

Release Date Price: R$5.5 (-0.72%)

Transcript

Key Points

Positve

Allianca Saude e Participacoes SA (BSP:AALR3) achieved the highest revenue ever recorded for the first half of the year, reaching BRL 645 million.
The B2B segment showed significant growth, with a 31% increase in revenue compared to the same period last year.
The company reported an adjusted EBITDA growth of 12% for the quarter, indicating strong profitability.
Debt levels have decreased significantly, with a net debt to adjusted EBITDA ratio reaching the lowest level since the company's IPO in 2016.
Strategic acquisitions, such as Grupo Medi, are expected to add over BRL 250 million annually to consolidated gross revenue, strengthening the company's market position.

Negative

Gross revenue for the last 12 months showed a slight decline compared to the previous quarter due to the discontinuation of underperforming units.
There was a reduction in gross revenue by BRL 12 million this quarter, despite maintaining profitability.
The company faces challenges in maintaining performance across all units, with ongoing evaluations needed to maximize profitability.
The macroeconomic scenario presents uncertainties that could impact future financial decisions and strategies.
Despite recent acquisitions, the company must remain cautious with M&A activities to avoid short-term cash impacts and maintain leverage levels.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AALR3.SA - Allianca Saude e Participacoes SA
Q2 2025 Allianca Saude e Participacoes SA Earnings Call
Aug 15, 2025 / 04:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon everyone and thank you for waiting.

You're welcome to Aliza Sauddi's 2nd quarter 25 earnings conference call. We will begin the presentation which will be given by Mr. Ricardo Sartin, CEO, and Mr. Pedro Givon, chief financial and investor relations officer. Also joining us today is Mr. Jose Ramos, Chief legal and compliance officer. At the end of this conference, we will have a Q&A session to address the eventual questions you may have. If you wish to participate, please send us a message, click.

The button below, the chat button. You may send your questions at any time, even during the presentations. This conference call will be recorded and will be available on the

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.